NEW YORK (GenomeWeb) – NanoString Technologies said today that it has calculated preliminary total revenue of approximately $25.9 million to $26.9 million for the third quarter of 2017, which includes product and service revenue of approximately $16.9 million — a significant shortfall from the firm's previous guidance of $19.5 million to $21.5 million from products and services.

NanoString President and CEO Brad Gray attributed the discrepancy to softness in the company's instrument and consumable sales over the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.